Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 W University Ave
# Cancer
Muncie, IN 47303Phone+1 765-282-8905Fax+1 765-747-8452
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1968 - 1973
- Perelman School of Medicine at the University of PennsylvaniaClass of 1968
Certifications & Licensure
- IN State Medical License 1973 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Publications & Presentations
PubMed
- 51 citationsUpdated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation w...Shadia I. Jalal, H. D. Riggs, Anton Melnyk, Donald A. Richards, A. K. Agarwala
Annals of Oncology. 2012-07-01 - 26 citationsPemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II StudyShadia I. Jalal, Rafat Ansari, Ramaswamy Govindan, Sumeet Bhatia, D. Bruetman
Journal of Thoracic Oncology. 2009-01-01 - 19 citationsGefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.Anuj K. Agarwala, William B. Fisher, D. Bruetman, John McClean, David Taber
Journal of Thoracic Oncology. 2008-04-01
Press Mentions
- Shop TalkFebruary 10th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: